Danske Bank’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.71K Hold
200
﹤0.01% 970
2026
Q1
$1.2K Sell
200
-200
-50% -$1.5K ﹤0.01% 1015
2025
Q4
$2.87K Hold
400
﹤0.01% 1388
2025
Q3
$4.27K Hold
400
﹤0.01% 1326
2025
Q2
$3.87K Hold
400
﹤0.01% 1371
2025
Q1
$5.96K Hold
400
﹤0.01% 1151
2024
Q4
$5.97K Sell
400
-2,400
-86% -$39.1K ﹤0.01% 1184
2024
Q3
$53.6K Buy
+2,800
New +$58K ﹤0.01% 1180
2024
Q2
Sell
-246,281
Closed -$4.63M 1230
2024
Q1
$4.63M Buy
+246,281
New +$4.23M 0.01% 583

Other funds holding OGN

Danske Bank's OGN Position: Q2 2026 in Review

Danske Bank held its Organon & Co (OGN) position steady in Q2 2026 at 200 shares worth $2.71K. The position accounts for ﹤0.01% of the portfolio, ranked #970.

Danske Bank first reported a position in OGN in Q1 2024 and has held it in 9 quarters since. The position peaked at $4.63M in Q1 2024. 506 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Danske Bank held 200 shares of Organon & Co worth $2.71K as of Q2 2026.
  • Danske Bank left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #970 holding.
  • Danske Bank first reported a position in Organon & Co in Q1 2024 and has held it in 9 quarters since.
  • Danske Bank's Organon & Co position peaked at $4.63M in Q1 2024.
  • 506 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.